Freespira Breathing System

DEVICE2 trials

Sponsors

Johns Hopkins University, Palo Alto Health Sciences, Inc.

Conditions

AnxietyPanic DisorderStress Disorders, Post-Traumatic

Unknown Phase

The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens

TerminatedNCT02998502

Johns Hopkins UniversityAnxiety, Panic Disorder

Start: 2016-09-01End: 2021-01-30Target: 73Updated: 2026-09-03

Investigation of the Freespira Breathing System in the Treatment of Post Traumatic Stress Disorder (PTSD)

CompletedNCT03039231

Palo Alto Health Sciences, Inc.Stress Disorders, Post-Traumatic

Start: 2017-02-01End: 2019-08-25Updated: 2020-03-25

Related Papers

Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study

JMIR Research Protocols2024-06-179 citations